H.R. 6130 · In committee · Health
ASAP Act
Sponsor: Vern Buchanan (R-FL)
What it does
- Adds Alzheimer's disease and related dementias early detection screening tests to Medicare covered services, effective January 1, 2028.
- Defines covered tests as FDA-cleared, classified, or approved blood-based and biospecimen tests for pre-symptomatic and early-stage dementia detection, including genomic sequencing, protein analysis, imaging, and equivalent tests the Secretary deems appropriate.
- Amends Medicare payment rules to include payment for Alzheimer's disease and related dementias early detection screening tests under section 1861(nnn).
Latest action
Sep 16, 2026: Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 40 - 0.
Committee: House Ways and Means